University of Erlangen-Nurenberg, Division of Hematology/Oncology
About University of Erlangen-Nurenberg, Division of Hematology/Oncology
University of Erlangen–Nuremberg is a public research university in the cities of Erlangen and Nuremberg in Bavaria, Germany. The name Friedrich–Alexander comes from the university's first founder Friedrich, Margrave of Brandenburg-Bayreuth, and its benefactor Alexander, Margrave of Brandenburg-Ansbach.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Millennium Pharmaceuticals, Inc.
2
Clinical Trials at University of Erlangen-Nurenberg, Division of Hematology/Oncology
During the past decade, University of Erlangen-Nurenberg, Division of Hematology/Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
2002-06-01
2004-12-01
Completed
620
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
2002-04-01
2005-07-01
Completed
600
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Erlangen-Nurenberg, Division of Hematology/Oncology
According to Clinical.Site data, the most researched conditions in "University of Erlangen-Nurenberg, Division of Hematology/Oncology" are
"Multiple Myeloma" (2 trials). Many other conditions were trialed in "University of Erlangen-Nurenberg, Division of Hematology/Oncology" in a lesser frequency.
Clinical Trials Intervention Types at University of Erlangen-Nurenberg, Division of Hematology/Oncology
Most popular intervention types in "University of Erlangen-Nurenberg, Division of Hematology/Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "bortezomib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Erlangen-Nurenberg, Division of Hematology/Oncology
The vast majority of trials in "University of Erlangen-Nurenberg, Division of Hematology/Oncology" are
2 trials for "All" genders.
Clinical Trials Status at University of Erlangen-Nurenberg, Division of Hematology/Oncology
Currently, there are NaN active trials in "University of Erlangen-Nurenberg, Division of Hematology/Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of Erlangen-Nurenberg, Division of Hematology/Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Erlangen-Nurenberg, Division of Hematology/Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".